Table of Content

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Overview of Plant-based Biologics and Expression Systems
3.2. Classification of Plant-based Expression Platforms
3.3. Mechanism of Plant Expression Platform
3.4. Advantages Offered by Plant-based Bioproduction Systems
3.5. Commonly used Plant-based Bioproduction Systems
3.6. Key Developments
3.7. Future Perspectives

4. PLANT-BASED EXPRESSION SYSTEMS: MARKET LANDSCAPE
4.1. Plant-based Expression Systems: Market Overview and Developer Landscape
4.2. List of Plant-based Expression System Providers
4.2.1. Analysis by Type of Plant
4.2.2. Analysis by Type of Biologic
4.2.3. Analysis by Type of Plant and Type of Biologic
4.2.4. Analysis by Type of Biologic and Region
4.2.5. Analysis by Type of Plant, Type of Biologic and Region
4.2.6. Analysis by Type of Service
4.2.7. Analysis by Year of Establishment
4.2.8. Analysis by Company Size
4.2.9. Analysis by Region (Country-wise)
4.2.10. Analysis by Region (Continent-wise)

5. PLANT-BASED BIOLOGICS: MARKET LANDSCAPE
5.1. Plant-based Biologics: Pipeline Review and Developer Landscape
5.2. List of Drug Candidates
5.2.1. Analysis by Status of Development
5.2.2. Analysis by Target Disease Indication
5.2.3. Analysis by Therapeutic Area
5.2.4. Analysis by Status of Development and Therapeutic Area
5.2.5. Analysis by Type of Biologic
5.2.6. Analysis by Status of Development and Type of Product
5.3. Plant-based Biologics: List of Drug Developers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Region
5.3.3.1. Analysis of Players in North America
5.3.3.2. Analysis of Players in Europe
5.3.3.3. Analysis of Players in Asia and Rest of the World

6. COMPANY PROFILES
6.1. Medicago
6.1.1. Company Overview
6.1.2. Technology Portfolio
6.2.3. Recent Developments and Future Outlook
6.2. Leaf Expression Systems
6.2.1. Company Overview
6.2.2. Technology Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Eleva
6.3.1. Company Overview
6.3.2. Technology Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. iBIO
6.4.1. Company Overview
6.4.2. Technology Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. PlantForm
6.5.1. Company Overview
6.5.2. Technology Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. G+Flas Life Sciences
6.6.1. Company Overview
6.6.2. Technology Portfolio
6.6.3. Recent Developments and Future Outlook
6.7. Kentucky Bioprocessing
6.7.1. Company Overview
6.7.2. Technology Portfolio
6.7.3. Recent Developments and Future Outlook
6.8. Angany
6.8.1. Company Overview
6.8.2. Technology Portfolio
6.8.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Plant-based Biologics and Expression Systems: Partnerships and Collaborations
7.1.1. Analysis by Cumulative Year-wise Trend of Partnerships
7.1.2. Analysis by Type of Partnership
7.1.3. Analysis by Year and Type of Partnership
7.1.4. Analysis by Type of Biologic
7.1.5. Analysis by Type of Partnership and Type of Biologic
7.1.6. Key Players: Analysis by Number of Partnerships
7.1.7. Analysis by Partner Headquarters (Region)
7.1.8. Analysis by Region and Type of Agreement
7.1.9. Intercontinental and Intracontinental Partnerships

8. COMPANY COMPETITIVENESS ANALYSIS
8.1. Plant-based Expression System Providers: Company Competitiveness Analysis
8.1.1. Assumptions and Key Parameters
8.1.2. Methodology
8.3. Benchmarking of Portfolio Strength
8.4. Benchmarking of Partnership Strength
8.5. Company Competitiveness Analysis: Small Companies
8.6. Company Competitiveness Analysis: Mid-sized Companies
8.7. Company Competitiveness Analysis: Large Companies

9. PUBLICATIONS ANALYSIS
9.1. Plant-based Biologics and Expression Systems: Publications Analysis
9.1.1. Analysis Methodology
9.1.2. Key Parameters
9.2. Analysis by Year of Publication
9.3. Analysis by Type of Publication
9.4. Key Journals based on Publications Count
9.5. Analysis by Primary Author
9.6. Analysis by Publisher
9.7. Analysis by Primary Funding Body
9.8. Analysis by Journal Impact Factor
9.9. Analysis by Key Journals and Journal Impact Factor
9.10. Word Cloud: Emerging Focus Area
9.11. Timeline Analysis
9.11.1. Analysis by Article Type and Timeline of Receipt, Acceptance and ApprovalAnalysis by Article Type and Timeline of Receipt, Acceptance and Approval
9.11.2. Analysis by Journal Impact Factor and Timeline of Receipt, Acceptance and ApprovalAnalysis by Journal Impact Factor and Timeline of Receipt, Acceptance and Approval
9.11.3. Analysis by Grant Awarded and Timeline of Receipt, Acceptance and Approval
9.12. Benchmarking Methodology
9.13. Benchmarking Analysis
9.14. List of Top 50 Publications

10. PLANT-BASED EXPRESSION SYSTEMS: MARKET SIZING AND OPPORTUNITY ANALYSIS
10.1. Methodology and Key Assumptions
10.2. Segments Forecasted
10.3. Plant-based Expression Systems: Sales Forecast
10.4. Analysis by Type of Product: Global Sales Forecast, 2022 and 2035
10.4.1. Plant-based Expression Systems Market for Biosimilars, 2022-2035
10.4.2. Plant-based Expression Systems Market for Cell Therapies, 2022-2035
10.4.3. Plant-based Expression Systems Market for Gene Therapies, 2022-2035
10.4.4. Plant-based Expression Systems Market for Monoclonal Antibodies, 2022-2035
10.4.5. Plant-based Expression Systems Market for Vaccines, 2022-2035
10.4.6. Plant-based Expression Systems Market for Others, 2022-2035
10.5. Distribution by Type of Plant: Global Sales Forecast, 2022 and 2035
10.5.1. Plant-based Expression Systems Market for Algae, 2022-2035
10.5.2. Plant-based Expression Systems Market for Barley, 2022-2035
10.5.3. Plant-based Expression Systems Market for Benth, 2022-2035
10.5.4. Plant-based Expression Systems Market for Duckweed, 2022-2035
10.5.5. Plant-based Expression Systems Market for Lettuce, 2022-2035
10.5.6. Plant-based Expression Systems Market for Maize, 2022-2035
10.5.7. Plant-based Expression Systems Market for Moss, 2022-2035
10.5.8. Plant-based Expression Systems Market for Rice, 2022-2035
10.5.9. Plant-based Expression Systems Market for Tomato, 2022-2035
10.5.10. Plant-based Expression Systems Market for Tobacco, 2022-2035
10.5.11. Plant-based Expression Systems Market for Wheat Germ, 2022-2035
10.6. Analysis by Type of Expression System: Global Sales Forecast, 2022 and 2035
10.6.1. Plant-based Expression Systems Market for Stable Expression System, 2022-2035
10.6.2. Plant-based Expression Systems Market for Transient Expression System,2022-2035
10.7. Analysis by Region: Global Sales Forecast, 2022 and 2035
10.7.1. Plant-based Expression Systems Market in North America, 2022-2035
10.7.2. Plant-based Expression Systems Market in Europe, 2022-2035
10.7.3. Plant-based Expression Systems Market in Asia, 2022-2035
10.7.4. Plant-based Expression Systems Market in Latin America, 2022-2035
10.7.5. Plant-based Expression Systems Market in MENA, 2022-2035
10.7.6. Plant-based Expression Systems Market in Rest of the World, 2022-2035
11. PLANT-BASED BIOLOGICS: MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. List of Forecasted DrugsKey Parameters and Assumptions
11.2. List of Forecasted DrugsAnalysis Methodology
11.3. List of Forecasted Drugs
11.3.1. Elelyso, Protalix Biotherapeutics
11.3.1.1. Global Sales Forecast
11.3.1.2. Regional Sales Forecast
11.3.1.3. Net Present Value
11.3.1.4. Value Creation Analysis
11.3.2. PALFORZIA, Aimmune Therapeutics
11.3.2.1. Global Sales Forecast
11.3.2.2. Regional Sales Forecast
11.3.2.3. Net Present Value
11.3.2.4. Value Creation Analysis
11.3.3. OsrHSA, Healthgen Biotechnology
11.3.3.1. Global Sales Forecast
11.3.3.2. Regional Sales Forecast
11.3.3.3. Net Present Value
11.3.3.4. Value Creation Analysis
11.3.4. PRX-102, Protalix Biotherapeutics
11.3.4.1. Global Sales Forecast
11.3.4.2. Regional Sales Forecast
11.3.4.3. Net Present Value
11.3.4.4. Value Creation Analysis
11.3.5. Unnamed_1, Medicago
11.3.5.1. Global Sales Forecast
11.3.5.2. Regional Sales Forecast
11.3.5.3. Net Present Value
11.3.5.4. Value Creation Analysis
11.3.6. Unnamed_2, Medicago
11.3.6.1. Global Sales Forecast
11.3.6.2. Regional Sales Forecast
11.3.6.3. Net Present Value
11.3.7.4. Value Creation Analysis
11.3.7. PRX-110, Protalix Biotherapeutics
11.3.7.1. Global Sales Forecast
11.3.7.2. Regional Sales Forecast
11.3.7.3. Net Present Value
11.3.7.4. Value Creation Analysis
11.3.8. ZMapp, Mapp Biopharmaceutical
11.3.8.1. Global Sales Forecast
11.3.8.2. Regional Sales Forecast
11.3.8.3. Net Present Value
11.3.8.4. Value Creation Analysis
11.4. Global Plant-based Biologics Market: Analysis by Target Disease Indication, 2022 and 2035
11.4.1. Plant-based Biologics Market for Cirrhotic Ascites, 2022-2035
11.4.2. Plant-based Biologics Market for COVID-19, 2022-2035
11.4.3 Plant-based Biologics Market for Cystic Fibrosis, 2022-2035
11.4.4 Plant-based Biologics Market for Ebola Virus Infection, 2022-2035
11.4.5. Plant-based Biologics Market for Fabry Disease, 2022-2035
11.4.6. Plant-based Biologics Market for Gaucher Disease, 2022-2035
11.4.7. Plant-based Biologics Market for Influenza, 2022-2035
11.4.8. Plant-based Biologics Market for Liver Cirrhosis, 2022-2035
11.4.9. Plant-based Biologics Market for Peanut Allergy, 2022-2035
11.5. Plant-based Biologics Market: Analysis by Therapeutic Area, 2022 and 2035
11.5.1. Plant-based Biologics Market for Genetic Disorders, 2022-2035
11.5.2 Plant-based Biologics Market for Infectious Disorders, 2022-2035
11.5.3 Plant-based Biologics Market for Liver Disorders, 2022-2035
11.5.4. Plant-based Biologics Market for Respiratory Disorders, 2022-2035
11.5.5. Plant-based Biologics Market for Others, 2022-2035
11.6. Plant-based Biologics Market: Analysis by Region, 2022 and 2035
11.6.1. Plant-based Biologics Market in North America, 2022-2035
11.6.2. Plant-based Biologics Market in Europe, 2022-2035
11.6.3. Plant-based Biologics Market in Asia, 2022-2035
11.6.4. Plant-based Biologics Market in Rest of the World, 2022-2035
11.7. Plant-based Biologics: Overall Market Opportunity, 2022-2035
11.8. Plant-based Biologics: Market Share of Key Players
11.9. Plant-based Biologics: Regional Distribution, 2022,2028 and 2035
11.10. Region-wise Distribution (Bubble Chart Representation)

12. EXECUTIVE INSIGHTS
12.1. Transactiva
12.1.1. Company Snapshot
12.1.2. Interview Transcript: Sara Raccovelli (Researcher)
12.2. ORF Genetics
12.2.1. Company Snapshot
12.2.2. Interview Transcript: J?l?us B Kristinsson (Chief Project Manager, Business Development & Co-Founder)

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 1: PUBLICATIONS DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS